News

NewYork-Presbyterian Hospital/Columbia University Medical Center has appointed Tomoaki Kato, MD, Professor of Surgery, as Chief of the Division of Abdominal Organ Transplantation.

A majority of children who had received liver transplants from their parents were able to stop anti-rejection (immunosuppressant) medication in an encouraging study at three transplant centers.

For someone with liver disease, a cocktail is normally a forbidden luxury. But in some cases, it may be just what the doctor ordered. Two recently approved medications are now being combined with traditional treatments to form a powerful new drug cocktail, improving the outcomes among patients with this challenging disease.

Preserving organs on ice prior to transplantation, an approach known as cold storage or CS, has been the standard practice in liver transplant for 20 years. Now there is new evidence that a technique called hypothermic machine perfusion (HMP) may offer an improvement, according to the first-ever study comparing the impact of the two techniques on transplant outcomes. The phase I study was carried out by Dr. James Guarrera and his colleagues at NewYork-Presbyterian Hospital/Columbia University Medical Center. Unlike cold storage, which Dr. Guarrera describes as a static technique, HMP dynamically simulates "aliveness" by providing a continuous flow of oxygen and key nutrients to the liver while diluting and removing toxins and waste products.